Cerebrospinal fluid nitric oxide levels in childhood bacterial meningitis

Scandinavian Journal of Infectious Diseases

Volumn 31, Issue 5, 1999, Pages 518-520

  Uysal, Gülnar ^a,c   Yüksel, Gülten ^a   Sinav, Bahar ^b   Yüksel, Selçuk ^a   Uysal, Hilmi ^b  

^a Social Security Institution   (Turkey)

^b Sevgi Hospital   (Turkey)

^c Bilkent II   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; NITRATE; NITRIC OXIDE; NITRITE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID LEVEL; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INFANT; LEUKOCYTE COUNT; PROTEIN CEREBROSPINAL FLUID LEVEL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; MALE; MENINGITIS, BACTERIAL; NITRIC OXIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0344761918     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549950164120     Document Type: Article

References (27)

1. Milstien S, Sakai N, Brew BJ, Krieger C, Vickers JH, Saito K, et al. Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases. J Neurochem 1994; 63: 1178-80.
2. Visser JJ, Scholten RJPM, Hoekman K. Nitric oxide synthesis in meningococcal meningitis. Ann Intern Med 1994; 120: 345-6.
3. Kornelisse RF, Hoekman K, Visser JJ, Hop WCJ, Huijmans JGM, van der Straaten PJC, et al. The role of nitric oxide in bacterial meningitis in children. JID 1996; 174: 120-6.
4. Van Furth AM, Seijmonsbergen EM, Groeneveld PH, vann Furth R, Langermans JA. Levels of nitric oxide correlate with high levels of tumour necrosis factor alpha in cerebrospinal fluid samples from children with bacterial meningitis. Clin Infect Dis 1996; 22: 876-8.
5. Murawska E, Szychowska Z, Trebusiewicz B. Nitric oxide (NO) in children with meningitis. Przegl Epidemiol 1997; 51: 309-15.
6. Tsukahara H, Haruta T, Hata I, Mayumi M. Nitric oxide in septic and aseptic meningitis in children. Scand J Lab Invest 1998; 58: 73-80.
7. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
8. Dawson TM, Dawson VL, Snyder SH. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 1992; 32: 297-311.
9. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 1994; 63: 175-95.
10. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994; 120: 227-37.
11. Schmidt HHHW, Walter U. NO at work. Cell 1994; 78: 919-25.
12. Nathan CF, Hibbs JB. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Op Immun 1991; 3: 65-70.
13. Geng Y, Hansson GK, Holme E. Interferon-gamma and tumour necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circulation Res 1992; 71: 1268-76.
14. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-13.
15. Bastian NR, Hibbs JB. Assembly and regulation of NADPH oxidase and nitric oxide synthase. Curr Op Imm 1994; 6: 131-9.
16. Anggard E. Nitric oxide: mediator, murderer, and medicine. Lancet 1994; 343: 1199-206.
17. Koedel U, Bernatowicz A, Paul R, Frei K, Fontana A, Pfister HW. Experimental pneumococcal meningitis: Cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann Neurol 1995; 37: 313-23.
18. Paul R, Koedel U, Pfister HW. 7-Nitroindazole inhibits pial arteriolar vasodilation in a rat model of pneumococcal meningitis. J Cereb Blood Flow Metab 1997; 17: 985-90.
19. Pfister HW, Fontana A, Tauber MG, Tomasz A, Scheld WM. Mechanisms of brain injury in bacterial meningitis: workshop summary. Clin Infect Dis 1994; 19: 463-79.
20. Dalkara T, Moskowitz MA. Neurotoxic and neuroprotective roles of nitric oxide in cerebral ischaemia. In: Green AR, Cross AJ, eds. International review of neurobiology -neuroprotective agents and cerebral ischaemia. San Diego: Academic Press, 1997: 319-36.
21. Buster BL, Weintrob AC, Townsend GC, Scheld WM. Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats. Infect Immun 1995; 63: 3835-9.
22. Boje KM. Inhibition of nitric oxide synthase partially attenuates alterations in the blood-cerebrospinal fluid barrier during experimental meningitis in the rat. Eur J Pharmacol 1995; 272: 297-300.
23. Ikeda M, Sato I, Matsunaga T, Takahashi M, Yuasa T, Murota S. Cyclic guanosine monophosphate (cGMP), nitrite and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis and Guillain-Barre syndrome. Intern Med 1995; 34: 734-7.
24. Duke T, South M, Stewart A. Cerebrospinal fluid nitric oxide metabolites and discrimination of bacterial meningitis from other causes of encephalopathy. Arch Dis Child 1997; 76: 290.
25. Ignarro LJ, Fukuto JM, Griscavage JM, Rogers NE, Byrns RE. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc Natl Acad Sci USA 1993; 90: 8103-7.
26. Albina JE, Mastrofrancesco B. Modulation of glucose methabolism in macrophages by products of nitric oxide synthase. Am J Physiol 1993; 264 (Cell Physiol 33): C1594-9.
27. Tureen J. Effect of recombinant human tumour necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid laclate, and cerebral blood flow in the rabbit: role of nitric oxide. J Clin Invest 1995; 95: 1086-91.